Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine or 5-FU with Pegylated Interferon Alpha-2b in CSCC
NCT02218164Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Aug 2014
- Primary completion
- Jul 2017
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in cutaneous squamous cell carcinoma (cSCC), sponsored by Moffitt Cancer Center. Started Aug 2014; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT02218164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218164.